Persistence and compliance with osteoporosis therapies among postmenopausal women in the UK Clinical Practice Research Datalink

Real-world effectiveness of osteoporosis therapies for fracture reduction in post-menopausal women

(2018) Akeem A. Yusuf et al.   Archives of Osteoporosis

One and two-year persistence with different anti-osteoporosis medications: a retrospective cohort study

(2017) C. Reyes et al.   OSTEOPOROSIS INTERNATIONAL

Fracture liaison services: improving outcomes for patients with osteoporosis

(2017) Samuel Walters et al.   Clinical Interventions in Aging

Persistence with denosumab therapy in women affected by osteoporosis with fragility fractures: a multicenter observational real practice study in Italy

(2017) S. Migliaccio et al.   JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION

Two-year persistence and compliance with osteoporosis therapies among postmenopausal women in a commercially insured population in the United States

(2017) Emily Durden et al.   Archives of Osteoporosis

Factors associated with high 24-month persistence with denosumab: results of a real-world, non-interventional study of women with postmenopausal osteoporosis in Germany, Austria, Greece, and Belgium

(2017) A. Fahrleitner-Pammer et al.   Archives of Osteoporosis

GRAND-4: the German retrospective analysis of long-term persistence in women with osteoporosis treated with bisphosphonates or denosumab

(2016) P. Hadji et al.   OSTEOPOROSIS INTERNATIONAL

Non-adherence with bisphosphonates among patients with osteoporosis: impact on fracture risk and healthcare cost‏

(2016) Gabriel Chodick et al.   Expert Review of Pharmacoeconomics & Outcomes Research

Persistence with denosumab and zoledronic acid among older women: a population-based cohort study

(2016) Éric Tremblay et al.   Archives of Osteoporosis

A Retrospective Longitudinal Database Study of Persistence and Compliance with Treatment of Osteoporosis in Hungary

(2015) Péter Lakatos et al.   CALCIFIED TISSUE INTERNATIONAL

Adherence to denosumab in the treatment of osteoporosis and its utilization in the Czech Republic

(2015) Leos Fuksa et al.   CURRENT MEDICAL RESEARCH AND OPINION

Persistence with denosumab therapy among osteoporotic women in the Canadian patient-support program

(2015) Alexandra Papaioannou et al.   CURRENT MEDICAL RESEARCH AND OPINION

Data Resource Profile: Clinical Practice Research Datalink (CPRD)

(2015) Emily Herrett et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

The impact of persistence with bisphosphonates on health resource utilization and fracture risk in the UK: a study of patient records from the UK Clinical Practice Research Datalink

(2015) Samara Ferguson et al.   JOURNAL OF EVALUATION IN CLINICAL PRACTICE

Persistence, adherence, and medication-taking behavior in women with postmenopausal osteoporosis receiving denosumab in routine practice in Germany, Austria, Greece, and Belgium: 12-month results from a European non-interventional study

(2015) P. Hadji et al.   OSTEOPOROSIS INTERNATIONAL

Persistence with denosumab and persistence with oral bisphosphonates for the treatment of postmenopausal osteoporosis: a retrospective, observational study, and a meta-analysis

(2015) L. Karlsson et al.   OSTEOPOROSIS INTERNATIONAL

Switch patterns of osteoporosis medication and its impact on persistence among postmenopausal women in the UK General Practice Research Database

(2014) Lin Li et al.   MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY

Persistence at 12 months with denosumab in postmenopausal women with osteoporosis: interim results from a prospective observational study

(2014) S. L. Silverman et al.   OSTEOPOROSIS INTERNATIONAL

Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National Osteoporosis Guideline Group (NOGG) update 2013

(2013) J. Compston et al.   MATURITAS

Interventions to improve osteoporosis medication adherence and persistence: a systematic review and literature appraisal by the ISPOR Medication Adherence & Persistence Special Interest Group

(2013) M. Hiligsmann et al.   OSTEOPOROSIS INTERNATIONAL

Osteoporosis in the European Union: a compendium of country-specific reports

(2013) A. Svedbom et al.   Archives of Osteoporosis

Osteoporosis in the European Union: medical management, epidemiology and economic burden

(2013) E. Hernlund et al.   Archives of Osteoporosis

Does osteoporosis therapy invalidate FRAX for fracture prediction?

(2012) William D Leslie et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Persistence with osteoporosis medications among postmenopausal women in the UK General Practice Research Database

(2011) Lin Li et al.   MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY

Final results of the DAPS (Denosumab Adherence Preference Satisfaction) study: a 24-month, randomized, crossover comparison with alendronate in postmenopausal women

(2011) N. Freemantle et al.   OSTEOPOROSIS INTERNATIONAL

Individual patients hold different beliefs to prescription medications to which they persist vs nonpersist and persist vs nonfulfill

(2010) Colleen McHorney   Patient Preference and Adherence

Impact of Osteoporosis Treatment Adherence on Fracture Rates in North America and Europe

(2009) Ethel S. Siris et al.   AMERICAN JOURNAL OF MEDICINE

Fracture Outcomes Related to Persistence and Compliance With Oral Bisphosphonates

(2008) Arlene M Gallagher et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Medication Compliance and Persistence: Terminology and Definitions

(2007) Joyce A. Cramer et al.   VALUE IN HEALTH